Advertisement

Digestive Diseases and Sciences

, Volume 41, Issue 4, pp 754–763 | Cite as

Placebo-controlled trial of cisapride in postgastrectomy patients with duodenogastroesophageal reflux

  • Michael F. Vaezi
  • Richard Sears
  • Joel E. Richter
Esophageal, Gastric, and Duodenal Disorders

Abstract

Medical treatment of duodenogastroesophageal reflux in postgastrectomy patients has been disappointing. Using ambulatory esophageal bilirubin monitoring, we evaluated the efficacy of cisapride in this disorder. Ten chronically symptomatic partial gastrectomy patients (5 Billroth 1, 5 Billroth 11; 8 men; average age 57) with duodenogastroesophageal reflux were randomized to four weeks of either placebo or cisapride (20 mg four times a day) in a double-blind crossover study. Significantly improved patients continued to take cisapride for an additional four months. Duodenogastroesophageal reflux was assessed at baseline and after four weeks on each therapy. Daily diary recorded symptoms and mean monthly scores were determined. Global symptom improvements were assessed at the end of each treatment period. Compared to placebo, cisapride significantly (P<0.05) decreased duodenogastroesophageal reflux. Overall symptoms improved in 70% of patients on cisapride compared to 10% on placebo (P<0.01). Mean monthly scores significantly (P<0.05) improved for abdominal pain, regurgitation, and belching. These symptoms remained improved after four months of chronic therapy. We conclude that cisapride significantly reduces duodenogastroesophageal reflux and results in short- and long-term symptom improvements in postgastrectomy patients and that cisapride offers the first successful medical therapy for duodenogastroesophageal reflux in postgastrectomy patients.

Key Words

cisapride bilirubin monitoring bilitec duodenogastroesophageal reflux postgastrectomy patients 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gotley DC, Morgan AP, Cooper MJ: Bile acid concentrations in the refluxate of patients with reflux oesophagitis. Br J Surg 75:587–590, 1988Google Scholar
  2. 2.
    Gotley DC, Morgan AP, Ball D, Owens RW, Cooper MJ: Composition of gastro-oesophageal refluxate. Gut 32:1093–1099, 1991Google Scholar
  3. 3.
    Mackie C, Hulks G, Cuschieri A: Enterogastric reflux and gastric clearance of refluxate in patients with and without bile vomiting following peptie ulcer surgery. Ann Surg 204:537–542 1986Google Scholar
  4. 4.
    Muller-Lissner SA, Fimmel CJ, Sonnenberg A: Novel approach to quantify duodenogastric reflux in healthy volunteers and in patients with type I gastric ulcer. Gut 24:510–518, 1983Google Scholar
  5. 5.
    Schidlbeck NE, Heinrich C, Stellard F, Paumgartner G, Muller-Lissner SA: Healthy controls have as much bile reflux as gastric ulcer patients. Gut 28:1577–1583, 1987Google Scholar
  6. 6.
    King PM, Pryde A, Heading RC: Transpyloric fluid movement and antroduodenal motility in patients with gastroesophageal reflux. Gut 28:545–548, 1987Google Scholar
  7. 7.
    Keane FB, Dimagno EP, Malagelada JD: Duodenogastric reflux in humans: Its relationship to fasting antroduodenal motility and gastric, pancreatic and biliary secretions. Gastroenterology 81:726–731, 1981Google Scholar
  8. 8.
    Burden WR, Hodges RP, Hsu M, O'Leary JP: Alkaline reflux gastritis. Surg Clin North Am 71:33–44, 1991Google Scholar
  9. 9.
    Dixon MF: Progress in pathology of gastritis and duodenitis.In Current Topies in Pathology GT Williams (ed). Berlin, Springer-Verlag, 1990, pp. 1–39Google Scholar
  10. 10.
    DuPlessis DJ: Pathogenesis of gastric ulceration. Lancet 1:974–978, 1965Google Scholar
  11. 11.
    Ritchie WP: Alkaline reflux gastritis: a critical reappraisal. Gut 25:975–987, 1984Google Scholar
  12. 12.
    Harmon JW, Bass BL, Batzri S: Alkaline reflux gastritis.In Problems in General Surgery. LL Nyhus (ed). Philadelphia. Lippincott, 1993, pp. 201–206Google Scholar
  13. 13.
    Woodward ER, Hocking MP: Postgastrectomy syndrome. Surg Clin North Am 67:509–520, 1987Google Scholar
  14. 14.
    Bondurant FJ, Maull KI, Nelson HS, Silver SH: Bile reflux gastritis. South Med J 80:161–165, 1987Google Scholar
  15. 15.
    Eagon JC, Miedema BW, Kelly KA: Postgastrectomy syndrome. Surg Clin North Am 72:445–465, 1992Google Scholar
  16. 16.
    Stabile BE, Passaro E Jr: Sequelae of surgery for peptic ulcer.In Bockus Gastroenterology. ed 4. JE Berck (ed). Philadelphia, Saunders, 1985, pp 1225–1254Google Scholar
  17. 17.
    Pera M, Trastek VF, Carpenter HA: Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. Ann Thorac Surg 55:1386–1393, 1993Google Scholar
  18. 18.
    Bechi P, Amorosi A, Mazzanti R: Gastric histology and fasting bile reflux after partial gastrectomy. Gastroenterology 93:335–343, 1987Google Scholar
  19. 19.
    Sobala GM, O'Connor HJ, Dewar EP: Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol 46:235–240, 1993Google Scholar
  20. 20.
    Lawson HH: Effect of duodenal contents on the gastric mucosa under experimental conditions. Lancet 1:469–472, 1964Google Scholar
  21. 21.
    Lillemoe KD, Johnson LE, Harmon JW: Alkaline esophagitis: A comparison of the ability of components of gastroduodenal contents to injure rabbit mucosa. Gastroenterology 85:621–628, 1983Google Scholar
  22. 22.
    Delaney JP, Broadie TA, Robbins PL: Pyloric reflux gastritis: the offending agent. Surgery 77:764–772, 1975Google Scholar
  23. 23.
    Ritchie WP: Postoperative alkaline reflux gastritis: A prospective clinical study of aetiology and treatment. Scand J Gastroenterol 16:233–235, 1981Google Scholar
  24. 24.
    Stefaniwsky AB, Tint GS, Shefer SS, et al: Ursodeoxy acid treatment of bile reflux gastritis. Gastroenterology 89:1000–1004, 1985Google Scholar
  25. 25.
    Buch KL, Weinstein WM, Hill TA: Sucralfate therapy in patients with symptoms of alkaline reflux gastritis. Am J Med 79:49–54, 1985Google Scholar
  26. 26.
    Nicolai JJ, van de Stadt J, Tytgat GN: Double-blind crossover trial of prostaglandin E2 in postgastrectomy reflux gastritis. Dig Dis Sci 31:1281–1286, 1986Google Scholar
  27. 27.
    Malagelada JR, Philips SF, Shorter RG: Postoperative reflux gastritis: Pathophysiology and longterm outcome after Rouxen-Y diversion. Ann Intern Med 103:178–183, 1985Google Scholar
  28. 28.
    Boren C, Way LW: Alkaline reflux gastritis. A reevaluation. Am J Surg 140:40–46, 1980Google Scholar
  29. 29.
    Pellegrini CA, Patti MG, Lewin M, et al: Alkaline reflux gastritis and the effect of biliary diversion on gastric emptying of solid foods. Am J Surg 150:166–171, 1985Google Scholar
  30. 30.
    Davidson ED, Hersh T: Bile reflux gastritis. Contribution of inadequate gastric emptying. Am J Surg 130:514–518, 1975Google Scholar
  31. 31.
    Wiseman LR, Faulds D: Cisapride: An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 47:116–152, 1994Google Scholar
  32. 32.
    Testoni PA, Masci E, Bagnolo F: Effect of longerm oral therapy with cisapride in reflux antral gastritis. Curr Ther Res 47:156–165, 1990Google Scholar
  33. 33.
    Bechi P, Pucciani F, Baldini F, Cosi F, Falciai R, Mozzanti R: Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique. Dig Dis Sci 38:1297–1306, 1993Google Scholar
  34. 34.
    Vaezi MF, LaCamera RG, Richter JE: Validation studies of Bilitee 2000: An ambulatory duodenogastric reflux monitoring system. Am J Physiol 30:G1050-G1057, 1994Google Scholar
  35. 35.
    Champion G, Richter JE, Vaezi MF: Duodenogastroesophageal reflux: Relationship to pH and importance in Barrett's esophagus. Gastroenterology 107:747–754, 1994Google Scholar
  36. 36.
    Vaezi MF, Richter JE: Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 117:699–704, 1995Google Scholar
  37. 37.
    Richter JE, Wu WC, Johns DN: Esophageal manometry in 95 healthy adult volunteers: Variability of pressures with age and frequency of abnormal contractions. Dig Dis Sci 32:583–592, 1987Google Scholar
  38. 38.
    Richter JE, Bradley LA, DeMeester TR: Normal 24-hour ambulatory esophageal pH values: Influence of study center. pH electrode, age, and gender. Dig Dis Sci 37:849–856, 1992Google Scholar
  39. 39.
    Vaezi MF, Richter JE: Role of acid and bile in gastroesophageal reflux disease. Gastroenterology 108:A922, 1995Google Scholar
  40. 40.
    Vaezi MF, Singh S, Richter JE: Role of acid and duodenogastric reflux in esophageal mucosal injury: A review of animal and human studies. Gastroenterology 108:1897–1907, 1995Google Scholar
  41. 41.
    Mittal RK, Reuben A, Whitney JO: Do bile acids reflux into the esophagus? A study in normal subjects and patients with GERD. Gastroenterology 92:371–375, 1987Google Scholar
  42. 42.
    Pellegrini CA, DeMeester TR, Wernly JA, Johnson LF, Skinner DB: Alkaline gastroesophageal reflux. Am J Surg 75:177–184, 1978Google Scholar
  43. 43.
    Mattioli S, Pilotti V, Felice V, Lazzari A, Zannoli R, Bachi ML: Ambulatory 24-hour pH monitoring of the esophagus, fundus, and antrum. Dig Dis Sci 35:929–938, 1990Google Scholar
  44. 44.
    Singh S, Bradley LA, Richter JE: Determinants of ocsophageal “alkaline” pH environment in controls and patients with gastro-oesophageal reflux disease. Gut 34:309–316, 1993Google Scholar
  45. 45.
    Devault KR, Georgeson S, Castell DO: Salivary stimulation mimics esophageal exposure to refluxed duodenal contents. Am J Gastroenterol 88:1040–1043, 1993Google Scholar
  46. 46.
    Sears RJ, Champion G, Richter JE: Characteristics of partial gastrectomy (PG) patients with esophageal symptoms of duodenogastric reflux. Am J Gastroenterol 90:211–215, 1995Google Scholar
  47. 47.
    Patterson DJ: Prokinetic agents in postgastrectomy patients. Gastroenterol Clin North Am 23:313–325, 1994Google Scholar
  48. 48.
    Petersen JM, Lange R, McCallum RW: Cisapride accelerates gastric emptying of solid and liquid meal components in patients with gastric statis. Dig Dis Sci 30:A788, 1985Google Scholar
  49. 49.
    Van der Mijle HCJ, Beckhuis H, Bleichrodt RP: Cisapride in treatment of Roux-en-Y syndrome. Dig Dis Sci 36:1691–1696, 1991Google Scholar
  50. 50.
    McCallum RW, Petersen J, Dubovie S: Effect of cisapride on gastric emptying and symptoms associated with gastroparesis. Gastroenterology 50:A1541, 1986Google Scholar
  51. 51.
    Kruening J, Arndt JW: Cisapride accelerates gastric emptying after vagotomy, but not after partial gastrectomy. Gut 30:A724, 1989Google Scholar
  52. 52.
    Ceccatelli P, Janssens J, Vantrappen G: Cisapride restores the decreased lower esophageal sphincter pressure in reflux patients. Gut 29:631–635, 1988Google Scholar
  53. 53.
    Fraser R, Horowitz M, Maddox A: Dual effects of cisapride of gastric emptying and antropyloroduodenal motility. Am J Physiol 3:G195-G201, 1993Google Scholar

Copyright information

© Plenum Publishing Corporation 1996

Authors and Affiliations

  • Michael F. Vaezi
    • 1
    • 2
  • Richard Sears
    • 1
    • 2
  • Joel E. Richter
    • 1
    • 2
  1. 1.Division of GastroenterologyUniversity of Alabama at BirminghamBirmingham
  2. 2.Department of GastroenterologyThe Cleveland Clinic FoundationCleveland

Personalised recommendations